Investors Pick Up ESPR Even Lower Than Its Secondary Stock Offering
August 11, 2017 at 10:07 AM EDT
Looking back to 2 days ago, Esperion Therapeutics Inc (ESPR) priced a 3,100,000 share secondary stock offering at $49.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..